Cushing’s Disease Market Size, Share, Trends, Growth Opportunities And Competitive Outlook
In recent years, the Cushing's disease market is anticipated to grow rapidly during the forecast period. Cushing's syndrome is a group of symptoms brought on by a high hormone cortisol level. The syndrome, also known as hypercortisolism, is frequently induced by corticosteroid medication adverse effects. Inflammation and autoimmune diseases are commonly treated with corticosteroids. Iatrogenic Cushing's syndrome and endogenous Cushing's syndrome are the two kinds of Cushing's syndrome. Weight gain, adipose tissue deposits around the abdomen and back, purple stretch marks, thinner skin that is easily bruised, acne, and other symptoms are common. Data Bridge Market Research analyses that the Cushing's disease market was valued at USD 333.80 million in 2021 and is expected to reach USD 686.89 million by 2029, registering a CAGR of 9.44% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework..
Comments
Post a Comment